UroGen Pharma (NasdaqGM:URGN) FY Conference Transcript
UroGen Pharma (NasdaqGM:URGN) FY Conference September 08, 2025 09:00 AM ET Company ParticipantsChris Degnan - CFODaniel Smith - Equity Research AssociateMark Schoenberg - Chief Medical OfficerChris DegnanYes, Christopher Degnan.Daniel SmithNow I'm in. With my written.Chris DegnanAwesome.Daniel SmithLet me pull up, scared by a call.Good morning, everyone, and thank you for joining day one of the H.C. Wainwright & Co. Annual Global Investment Conference.My name is Daniel Smith. I'm an H.C. Wainwright Equity R ...